My Watchlist for Thursday, September 22

( click to enlarge )
In line with my anticipation, Juno Therapeutics Inc (NASDAQ:JUNO) confirmed today the reversal when it broke the downtrend line that had been in place since June. This momentum could push this stock much higher from here, so keep it on the radar. Next major resistance lies around the $34 level.

( click to enlarge )
Neothetics Inc (NASDAQ:NEOT) Thin name with a good looking chart. After consolidating sideways the last few days with an upward bias, the stock broke out upwards today accompanied by a volume surge. Could move toward 1.50 area if it breaks and closes above the declining 100-day EMA. The daily technical chart is bullish short-term with a lot of indicators showing up.

( click to enlarge )
BlackBerry Ltd (NASDAQ:BBRY) could move toward 8.30 area if it breaks current horizontal resistance at 7.82. Technical indicators are showing signs of turning around.

( click to enlarge )
Coiling up here. Celldex Therapeutics, Inc. (NASDAQ:CLDX) is potential breakout trade above 3.76 resistance area.

( click to enlarge )
Digital Ally, Inc. (NASDAQ:DGLY) MACD crossover and looking to see if stock can get over 6.34 for nice bounce into 7's

( click to enlarge )
Facebook Inc (NASDAQ:FB) watch for trend continuation toward 132 zone short-term.

( click to enlarge )
I'm watching Amazon (NASDAQ:AMZN) for a possible breakout from current rectangle pattern. Could accelerate if it breaks 790.79 resistance.

If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email

Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.